FOR IMMEDIATE RELEASE

June 29, 2011 (Irvine, California) - BioMedGPS, a provider of real-time business intelligence and online decision-making tools for life science executives, announces the introduction of SmartTRAK Wound Biologics as the newest addition to the SmartTRAK Business Intelligence database. SmartTRAK Wound Biologics is a comprehensive and real-time online platform that tracks all of the public and privately-held companies developing dermal/skin substitutes, topically delivered biologic products and collagen/composite dressings on the market or under development worldwide, along with 5-year US market forecasts. SmartTRAK Wound Biologics is the only source for up-to-date business information on companies, products and markets in this emerging arena.

According to SmartTRAK, the US market for Wound Biologic products will reach an estimated $554 million in 2011 and will grow at a rate of 18.8% to approximately $1,058 million in 2015. The SmartTRAK Wound Biologics database is currently tracking more than 90 companies and 110+ biological products including cell-based bioengineered tissues, stem cells, growth factors and topical drugs, as well as collagen dressings. Over one-third of products in the SmartTRAK Wound Biologics database are under development or in clinical trials.  Also included in the database is a detailed US Market Profile, with 5-year sales forecasts, competitive market shares, regulatory information, as well as information on the complex reimbursement environment that is key to success in this market.

“The Wound Biologics market has taken center stage with the impressive growth of cell-based bioengineered products,” reports Sharon O’Reilly, Founder, President and CEO of BioMedGPS, the developer of the SmartTRAK Business Intelligence System. “A market driven by aging demographics and conditions associated with poor vascularity, the Wound Biologics market has garnered the attention of medical device, drug and biotech companies as well as allograft processors for good reason.  Any company looking to expand into this rapidly growing market can find all of the up-to-date information they need in one place—the SmartTRAK Wound Biologics database.”

Designed to replace print market and technology reports widely used in the industry today, the powerful SmartTRAK Online Business Intelligence system is transforming the delivery of medical device business information from static data to real-time analysis. SmartTRAK tracks emerging companies, competitive developments, regulatory approvals and strategic alliances, and presents this information in concise market, company and product profiles that are updated as industry developments occur. SmartTRAK allows users to search, sort, store and share information—increasing the productivity of business/corporate development, marketing, market research, R&D and other device executives, and saving companies money.

To read more about SmartTRAK Wound Biologics, visit http://biomedgps.com/wound. Online subscriptions are also available for the SmartTRAK OrthoBio and Spine databases, which together are tracking more than 465 companies and 1,530 products to date, with Extremities and Total Joint modules coming soon.

Register for a free 30-day trial of SmartTRAK Wound, OrthoBio, Spine, Extremities or Total Joint weekly Updates at http://www.biomedgps.com/smarttrak-updates.

CONTACT:

Sharon O'Reilly or Tracy Neilssien
949-559-5511
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.biomedgps.com